Chiara Re
@ChiaraRe
Followers
109
Following
220
Statuses
29
MD | Research Fellow at Cambridge University | Clinical Fellow at CUH, UK | Resident in Urology at San Raffaele Hospital, Milan
Joined April 2022
RT @DrChoueiri: In @EUplatinum during @kidneycan #KCRS24. Thank you Axel and Grant for leading the charge ! https:…
0
23
0
Truly honoured to have joined the first edition of the Florence Multidisciplinary Expert Meeting on RCC. Two inspiring days of lectures, debates, and new collaborations with the top European minds in the field. @Flo_exp_RCC_25 @Ric_Campi @u_capitanio @_alelarcher @grantissimus
0
1
17
RT @DrChoueiri: IT IS THIS TIME OF THE YEAR AGAIN! TOP 10 GU Bladder/Kidney Cancer TRIALS FOR 2024 1/ Enfortumab Vedotin (EV) + Pembroliz…
0
242
0
RT @DrChoueiri: Here we go: News from Europe and the @EMA_News: the first HIF2 inhibitor Belzutifan (already @US_FDA) receives POSITIVE opi…
0
18
0
RT @CRUKCamUrol: 🎉EXCITING NEWS 👇 @CRUKCamUrol researchers, led by @grantissimus and @JulietU_S, have published the world’s first prospect…
0
6
0
Extremely true!
Doing good science is 90% finding a science buddy to constantly talk to about the project.
0
0
1
RT @neerajaiims: Just in @NEJM 👉the primary results of ph3 @SWOG 1011 trial (n=592)👉in pts with muscle-invasive #bladdercancer undergoing r…
0
64
0
Save the date🚨 Oct 18-20 @SanRaffaeleMI and @MyUniSR host the leading global experts in Von Hippel-Lindau disease and #renalcancer
There are already more than 100 VHL experts registered for the 16th Annual VHL Symposium in Milan Oct 19-20 This event is open to VHL clinicians, researchers, and patients alike! Click here to learn more:
0
1
2
RT @Uroweb: History in the making: at #ERUS24 Prof @AlbertoBreda1 performs a partial nephrectomy from Bordeaux, France on a patient nearly…
0
40
0
RT @neerajaiims: Just in @TheLancetOncol 👉Zr-girentuximab PET–CT is highly accurate for detecting ccRCC #kidneycancer (like PSMA-PET in pro…
0
62
0
RT @kidneycan: Out today in @TIME — a review of recent advances in #KidneyCancer treatment highlighting the incredible work of @DrChoueiri…
0
20
0
RT @CMercinelli: Finally out on @JCO_ASCO #NureCombo!Neoadj Nivo/ABX achieved a ypT</=1N0-x in 70.9% pts. In the ITT population 32.3% pCR…
0
11
0
RT @DrChoueiri: 1/ Results from #LITESPARK-005 are out @NEJM! The phase 3 trial that led to HIF-2 inhibitor Belzutifan (BEL) @US_FDA appro…
0
143
0
RT @RobertoBurioni: Immaginarlo 35 anni fa era pensare a un miracolo. Invece è la realtà, una fantastica conquista della scienza. https://t…
0
373
0
RT @tompowles1: A commentary on diagnosis and treatment of renal cell cancer @TheLancet with @b_szabados and Matthew Young. It covers broad…
0
56
0
RT @francesco_cei1: Our team has developed a new model that accurately predicts partial nephrectomy outcomes based on patient data, tumor c…
0
5
0
Truly honoured to receive this recognition! Thanks to all the @BJUIjournal Editorial Board. Special thanks to @grantissimus for his daily mentorship & inspiration!
Thanks and congratulation to May's BJUI #ReviewersOfTheMonth
@LAUrology_NL @TNeerhut @ChiaraRe & @dmsomford Read more here:
1
4
18
0
11
0
RT @mattialongoni: 18F-FDG #PETCT showed high specificity & NPV for LNI detection in #Bladdercancer patients. Subgroup analyses confirm its…
0
2
0